Tirecat Health plans to fight fatal chronic diseases with its novel materials, bioinspired membranes that have demonstrated great preclinical results in multiple indications. The company has the ability to fine tune its proprietary technology to tackle a wide pool of potential indications; from completely changing the material composition obtaining different core properties, to adding small molecules and even changing its mechanical behaviour. Now, the company is moving towards the clinical stage to demonstrate safety and preliminary efficacy on the first intended indication. 

While we update information on clinical results and the selected indications, check: